BDBM435134 3-fluoro-4-(1-(2- methyl-6-(1- (trifluoromethyl)cyclo- propyl)benzoyl)-1H- pyrazolo[4,3- b]pyridin-3- yl)benzoic acid::US10584121, Example 1C

SMILES Cc1cccc(c1C(=O)n1nc(-c2ccc(cc2F)C(O)=O)c2ncccc12)C1(CC1)C(F)(F)F

InChI Key InChIKey=JNZCCNGPIZRVPY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 435134   

TargetNuclear receptor ROR-gamma(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM435134(US10584121, Example 1C | 3-fluoro-4-(1-(2- methyl-...)
Affinity DataIC50: 4.10nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2020
Entry Details
US Patent